From: Identification of targetable kinases in idiopathic pulmonary fibrosis
IPF | Age (years) | Sex | Smoking history (pack-years) | Time from IPF diagnosis to surgery | IPF treatment | Lung cancer type | Gene analysis of lung cancer | Surgical procedure | Number of samples |
---|---|---|---|---|---|---|---|---|---|
Case 1 | 57 | Male | 132 | 7Â years | None | SCC* | NA | Lung transplantation | 6 |
Case 2 | 67 | Male | 23.5 | 4Â years | None | SCC | EGFR- | Lobectomy | 3 |
Case 3 | 61 | Male | 82.5 | 5 years | Pirfenidone | – | NA | Lung transplantation | 2 |
Case 4 | 56 | Male | 82.5 | 3Â months | None | SCC | NA | Lobectomy | 1 |
Case 5 | 56 | Male | 36 | 3Â weeks | None | SCC | NA | Lobectomy | 1 |
Control | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Case 1 | 45 | Male | 15 | – | – | ADC | EGFR Ex18 G719S | Lobectomy | 2 |
Case 2 | 82 | Male | 45 | – | – | SCC | NA | Lobectomy | 2 |
Case 3 | 65 | Female | 22.5 | – | – | ADC | KRAS Q61H | Lobectomy | 2 |
Case 4 | 63 | Female | 0 | – | – | ADC | EGFR- | Lobectomy | 2 |